Centrum 7/6  banner

CUREfilm

CURE Pharmaceutical releases new drug delivery line

CURE Pharmaceutical releases new drug delivery line

OXNARD, Calif.  – CURE Pharmaceutical announces the expansion of its oral drug delivery product line creating CUREform which includes CUREfilm, one of the most advanced oral thin films on the market.  The new line adds CUREpods chewables and emulsions to meet increased demand for alternative dosage forms that can improve solubility and absorption. “Building on the

CURE Pharmaceutical to manufacture pharmaceuticals using whole cannabis plant

CURE Pharmaceutical to manufacture pharmaceuticals using whole cannabis plant

OXNARD, Calif. – CURE Pharmaceutical Tuesday announced it has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic cannabidiol (CBD). This license allows CURE to take advantage of its latest U.S. Patent No. 10,238,705 issuing this month for the extraction and purification of

PP_1170x120_10-25-21